News

“At Loyola, we determined four years ago that the rapid tests for influenza detected only 50 percent of the patients who were positive,” said Paul Schreckenberger, Ph.D., director

Callidus Software has signed a leading pharmaceutical company as a new customer for its on-demand Monaco suite. Under the agreement, signed in the fourth quarter of 2009, the

Genentech has submitted two supplemental Biologics License Applications (sBLAs) to the FDA for Avastin (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic)

Sun Pharma announced that the FDA has granted tentative approval to an Abbreviated New Drug Application (ANDA) for generic Gleevec, imatinib mesylate tablets. These imatinib mesylate tablets, therapeutically

bioMerieux has entered into an agreement with GlaxoSmithKline (GSK) to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer

The RealTime ready Influenza A/H1N1 Detection Set is used in conjunction with the RealTime ready RNA Virus Master kit also provided by Roche. The assay is carried out

Novartis has signed an agreement with Sarawak Biodiversity Centre (SBC) and BiotechCorp to discover bioactive compounds. Alexander Jetzer-Chung, director of Novartis said that the memorandum of understanding (MoU)

Appian Labs has entered an exclusive development and commercial license agreement for AppiForm Modular Release System with Capsugel. The agreement provides for Capsugel to utilise the AppiForm Modular

Abbott Laboratories (Abbott) has received a warning from the US regulators as it fails to follow good manufacturing practices (GMPs) standards at its Des Plaines facility, reported Daily